Mutual of America Capital Management’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.5M Sell
156,242
-53,116
-25% -$3.9M 0.12% 153
2025
Q1
$23.9M Sell
209,358
-10,547
-5% -$1.2M 0.28% 42
2024
Q4
$11.1M Sell
219,905
-38,848
-15% -$1.96M 0.12% 145
2024
Q3
$12M Sell
258,753
-4,543
-2% -$210K 0.13% 135
2024
Q2
$8.55M Buy
263,296
+128,194
+95% +$4.17M 0.09% 202
2024
Q1
$3.4M Sell
135,102
-9,870
-7% -$249K 0.04% 669
2023
Q4
$4.71M Buy
144,972
+36,255
+33% +$1.18M 0.05% 478
2023
Q3
$2.96M Sell
108,717
-7,367
-6% -$201K 0.04% 678
2023
Q2
$2.58M Sell
116,084
-9,586
-8% -$213K 0.03% 801
2023
Q1
$2.72M Buy
125,670
+11,913
+10% +$258K 0.03% 772
2022
Q4
$2.31M Buy
113,757
+2,370
+2% +$48.1K 0.03% 843
2022
Q3
$2.86M Buy
111,387
+95,327
+594% +$2.44M 0.04% 686
2022
Q2
$382K Buy
16,060
+2,322
+17% +$55.2K ﹤0.01% 1153
2022
Q1
$309K Buy
13,738
+783
+6% +$17.6K ﹤0.01% 1209
2021
Q4
$257K Sell
12,955
-958
-7% -$19K ﹤0.01% 1279
2021
Q3
$274K Sell
13,913
-1,010
-7% -$19.9K ﹤0.01% 1253
2021
Q2
$328K Buy
14,923
+823
+6% +$18.1K ﹤0.01% 1250
2021
Q1
$335K Buy
14,100
+1,047
+8% +$24.9K ﹤0.01% 1227
2020
Q4
$341K Buy
13,053
+570
+5% +$14.9K ﹤0.01% 1170
2020
Q3
$217K Buy
12,483
+7,438
+147% +$129K ﹤0.01% 1209
2020
Q2
$85K Buy
5,045
+506
+11% +$8.53K ﹤0.01% 1211
2020
Q1
$54K Buy
4,539
+839
+23% +$9.98K ﹤0.01% 1269
2019
Q4
$45K Sell
3,700
-86
-2% -$1.05K ﹤0.01% 1373
2019
Q3
$54K Buy
3,786
+29
+0.8% +$414 ﹤0.01% 1320
2019
Q2
$42K Buy
3,757
+777
+26% +$8.69K ﹤0.01% 1382
2019
Q1
$35K Buy
2,980
+341
+13% +$4.01K ﹤0.01% 1378
2018
Q4
$35K Buy
2,639
+632
+31% +$8.38K ﹤0.01% 1320
2018
Q3
$28K Buy
2,007
+1,656
+472% +$23.1K ﹤0.01% 1389
2018
Q2
$6K Buy
+351
New +$6K ﹤0.01% 1332